Vivos Therapeutics partners with South Palm Cardiovascular to launch Florida sleep testing, treatment center

• Vivos Therapeutics signed definitive collaboration and operating agreements with South Palm Cardiovascular Associates to launch a regional sleep testing and treatment center.
• Parties will form AIM Florida, a physician-aligned management services organization; Vivos expects a 75% majority membership and economic interest.
• Center in Palm Beach County is expected to start treating patients and generating revenue in Q1 2027, subject to site selection and startup milestones.
• Initial operating plan targets about 250 patients per month; projected annual revenue up to USD 6 million with contribution margins of 30%+.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608280845PRIMZONEFULLFEED9817663) on August 28, 2026, and is solely responsible for the information contained therein.